Cargando…

miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA

BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Xuehua, Qiu, Jianwei, Kang, Haifeng, Wang, Yaming, Qian, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248379/
https://www.ncbi.nlm.nih.gov/pubmed/30510452
http://dx.doi.org/10.2147/CMAR.S161990
_version_ 1783372622776500224
author Yang, Xuehua
Qiu, Jianwei
Kang, Haifeng
Wang, Yaming
Qian, Junbo
author_facet Yang, Xuehua
Qiu, Jianwei
Kang, Haifeng
Wang, Yaming
Qian, Junbo
author_sort Yang, Xuehua
collection PubMed
description BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS: The expression of miR-125a-5p was detected using quantitative real-time PCR (qRT-PCR), biological functions of miR-125a-5p were assessed by cell counting kit-8, wound-healing, transwell invasion, and human umbilical vein endothelial cell (HUVEC) tube formation assays in vitro and animal experiments in vivo. RESULTS: We found that miR-125a-5p was downregulated in CRC tissues and cell lines, it inhibited CRC cell proliferation, migration, and invasion and reduced the ability of HUVECs to form tubes. Moreover, we verifed that miR-125a-5p suppressed CRC growth and metastasis in vivo. Additionally, we showed that VEGFA, a direct target gene of miR-125a-5p, could reverse the inhibitory effect caused by miR-125a-5p overexpression. CONCLUSION: miR-125a-5p might serve as a tumor suppressor in CRC and could be regarded as a potential therapeutic candidate for CRC.
format Online
Article
Text
id pubmed-6248379
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-62483792018-12-03 miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA Yang, Xuehua Qiu, Jianwei Kang, Haifeng Wang, Yaming Qian, Junbo Cancer Manag Res Original Research BACKGROUND: MiR-125a-5p has been reported to be involved in the development and progression of various cancers. However, the biological function and underlying mechanisms in colorectal cancer(CRC) still remain unclear. Here, we explored the potential biological roles of miR-125a-5p in CRC. METHODS: The expression of miR-125a-5p was detected using quantitative real-time PCR (qRT-PCR), biological functions of miR-125a-5p were assessed by cell counting kit-8, wound-healing, transwell invasion, and human umbilical vein endothelial cell (HUVEC) tube formation assays in vitro and animal experiments in vivo. RESULTS: We found that miR-125a-5p was downregulated in CRC tissues and cell lines, it inhibited CRC cell proliferation, migration, and invasion and reduced the ability of HUVECs to form tubes. Moreover, we verifed that miR-125a-5p suppressed CRC growth and metastasis in vivo. Additionally, we showed that VEGFA, a direct target gene of miR-125a-5p, could reverse the inhibitory effect caused by miR-125a-5p overexpression. CONCLUSION: miR-125a-5p might serve as a tumor suppressor in CRC and could be regarded as a potential therapeutic candidate for CRC. Dove Medical Press 2018-11-16 /pmc/articles/PMC6248379/ /pubmed/30510452 http://dx.doi.org/10.2147/CMAR.S161990 Text en © 2018 Yang et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Yang, Xuehua
Qiu, Jianwei
Kang, Haifeng
Wang, Yaming
Qian, Junbo
miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title_full miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title_fullStr miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title_full_unstemmed miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title_short miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA
title_sort mir-125a-5p suppresses colorectal cancer progression by targeting vegfa
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6248379/
https://www.ncbi.nlm.nih.gov/pubmed/30510452
http://dx.doi.org/10.2147/CMAR.S161990
work_keys_str_mv AT yangxuehua mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa
AT qiujianwei mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa
AT kanghaifeng mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa
AT wangyaming mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa
AT qianjunbo mir125a5psuppressescolorectalcancerprogressionbytargetingvegfa